Protein localization in the human eye and genetic screen of opticin
Open Access
- 16 April 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 11 (11) , 1333-1342
Abstract
The opticin (OPTC) gene encodes a protein that is a member of the small leucine-rich repeat protein (SLRP) family. OPTC is located on chromosome 1q31–q32 within an age-related macular degeneration (AMD) susceptibility locus. We have developed an affinity-purified N-terminal anti-opticin antibody and used it to examine opticin expression in human eye tissues. The antibody was also used for opticin protein localization in human eye sections. Immunoblots of human eye tissues detected a predominant band of approximately 62 kDa in size in iris, trabecular meshwork/ciliary body, retina, vitreous, and optic nerve. Immunohistochemical experiments revealed that opticin is specifically localized in human cornea, iris, ciliary body, vitreous, choroid and retina. Due to opticin's protein profile in the eye, we have also screened OPTC for mutations in individuals with primary open-angle glaucoma (POAG), normal-tension glaucoma (NTG) or AMD. We identified four sequence variations, all of which were observed in normal controls except for the Arg229Cys change. Three amino acid substitutions (Ile182Thr, Arg229Cys and Arg325Trp) were in residues conserved in dog, mouse, pig and human. The Arg229Cys alteration was present in a homozygous state in one individual with neovascular AMD. Examination of the other AMD afflicted family members showed that the OPTC Arg229Cys variant did not segregate with the disorder within the family. The protein localization pattern of opticin and our preliminary screen of AMD patients suggest that a larger AMD patient screen may be warranted.Keywords
This publication has 11 references indexed in Scilit:
- Cloning and characterization of opticin cDNA: evaluation as a candidate for canine oculo-skeletal dysplasiaGene, 2001
- Age-related maculopathy: an expanded genome-wide scan with evidence of susceptibility loci within the 1q31 and 17q25 regionsAmerican Journal of Ophthalmology, 2001
- Mutations in NYX, encoding the leucine-rich proteoglycan nyctalopin, cause X-linked complete congenital stationary night blindnessNature Genetics, 2000
- The complete form of X-linked congenital stationary night blindness is caused by mutations in a gene encoding a leucine-rich repeat proteinNature Genetics, 2000
- Mutations in KERA, encoding keratocan, cause cornea planaNature Genetics, 2000
- Identification in Vitreous and Molecular Cloning of Opticin, a Novel Member of the Family of Leucine-rich Repeat Proteins of the Extracellular MatrixJournal of Biological Chemistry, 2000
- Number of people with glaucoma worldwide.British Journal of Ophthalmology, 1996
- Visual disability and major causes of blindness in NSW: A study of people aged 50 and over attending the Royal Blind Society 1984 to 1989Australian and New Zealand Journal of Ophthalmology, 1991
- Blind registrations in Western Australia: a five‐year studyAustralian and New Zealand Journal of Ophthalmology, 1990
- Common causes of blindness and visual handicap in the west of Scotland.British Journal of Ophthalmology, 1983